General Partner Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$677K Hold
585
– – 0.36% 52
2026
Q2
$702K Hold
585
– – 0.38% 55
2026
Q1
$538K Sell
585
-25
-4% -$25.3K 0.33% 51
2025
Q4
$656K Hold
610
– – 0.37% 51
2025
Q3
$465K Hold
610
– – 0.26% 60
2025
Q2
$476K Hold
610
– – 0.28% 59
2025
Q1
$504K Buy
610
+10
+2% +$8.32K 0.33% 54
2024
Q4
$463K Hold
600
– – 0.28% 56
2024
Q3
$532K Hold
600
– – 0.33% 55
2024
Q2
$543K Hold
600
– – 0.35% 52
2024
Q1
$467K Buy
+600
New +$427K 0.29% 61

Other funds holding LLY

General Partner Inc's LLY Position: Q3 2026 in Review

General Partner Inc held its Eli Lilly (LLY) position steady in Q3 2026 at 585 shares worth $677K. The position accounts for 0.36% of the portfolio, ranked #52.

General Partner Inc first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. The position peaked at $702K in Q2 2026. 1,134 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • General Partner Inc held 585 shares of Eli Lilly worth $677K as of Q3 2026.
  • General Partner Inc left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.36% of General Partner Inc's portfolio in Q3 2026, its #52 holding.
  • General Partner Inc first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
  • General Partner Inc's Eli Lilly position peaked at $702K in Q2 2026.
  • 1,134 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on General Partner Inc's 13F filing for Q3 2026, filed 5 Oct 2026.